FIELD: chemistry.
SUBSTANCE: invention relates to the use of substituted pyrazolo[1.5-a]pyrido[3.4-e]pyrimidines, characterized by the following formula
wherein R1 is hydrogen or phenyl, R2 is hydrogen, R3 is a group selected from ethyl, 2-hydroxyethyl, 3-(N, N-dimethyl)-aminopropyl, 2-(morfilin-4-yl)ethyl, 3-carboxypromyl, 4-methoxybenzamide, ureido, methoxyacetamide 2-pyridin-3-ylmethyl, tetrahydrofuran-2-ylmethyl, 4-chlorobenzyl, 1,2,4-triazol-4-yl, as protein kinase inhibitors possessing anticancer activity.
EFFECT: detection of high inhibitory ability of compounds.
2 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
| 3-ACYLAMINOPYRIDIN DERIVATIVES, APPLICABLE AS SERINE-THREONINE PROTEINKINASE GSK3B INHIBITORS, AS MEDICATIONS FOR TYPE II DIABETES TREATMENT | 2013 |
|
RU2570907C2 |
| BICYCLIC AMINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | 2007 |
|
RU2465275C2 |
| POLYCYCLIC SUBSTITUTED PYRAZOLE KINASE ACTIVITY INHIBITORS AND USE THEREOF | 2014 |
|
RU2655921C2 |
| HETEROARYL-SUBSTITUTED PYRAZOLE-PYRIDINE PROTEIN KINASE INHIBITORS FOR STIMULATING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2020 |
|
RU2837173C2 |
| COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS | 2024 |
|
RU2838180C1 |
| SELECTIVE ANTITUBERCULOUS AGENTS REPRESENTING SUBSTITUTED 7-ARYL(HETERYL)-6-CARBETHOXY-4,7-DIHYDRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES OR SUBSTITUTED 7-ARYL(HETERYL)-4,7-DIHYDRO-6-NITRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE SALTS, PHARMACEUTICAL COMPOSITION THEREOF AND METHOD FOR PREPARATION OF SUBSTITUTED 7-ARYL(HETERYL)-6-CARBETHOXY-5-METHYL-4,7-DIHYDRO-1,2,4-TRIAZOLE[1,5-a]PYRIMIDINES | 2007 |
|
RU2360905C2 |
| IMIDAZOLONYL QUINOLINES AND USE THEREOF AS KINASE ATM INHIBITORS | 2016 |
|
RU2743343C2 |
| DERIVATIVES OF 2,4-SUBSTITUTED PHENYLENE-1,5-DIAMINE AND THEIR USES, PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS OBTAINED FROM THEM | 2015 |
|
RU2649001C1 |
